Pilot study of daily exemestane in women with complex atypical hyperplasia of the endometrium/endometrial intraepithelial neoplasia or grade 1 endometrial cancer
Ended Awarded Last action
- Contract number
- HHSN26100011
- Awardee
-
University Of Wisconsin System UEI LCLSJAGTNZQ7 Part of University Of Wisconsin System
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,219,744
Award facts
- Opportunity
-
- N01CN0501469 Solicitation number
- Cancer Prevention Agent Development Program: Early Phase Clinical Research Award Notice · Posted Mar 4, 2011
- Contract value 100% obligated
- $1,219,744.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Madison, WI 53715, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$146,434 | |
| Funding Only Action | -$107,221 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$4,829 | |
| Exercise an Option | $296,637 | |
| Change Order | $0 | |
| Exercise an Option | $107,353 | |
| Change Order | $107,221 | |
| Other Administrative Action | $0 | |
| Change Order | $409,406 | |
| Exercise an Option | $280,420 | |
| Other Administrative Action | $0 | |
| Original award | $277,191 |
Show all 14
About this award
The National Cancer Institute issued a delivery order to University of Wisconsin System (University of Wisconsin - Madison) on September 15, 2017, with a ceiling value of $1,219,744.24, under the Cancer Prevention Agent Development Program 2012-2017 parent IDIQ for a pilot study of daily exemestane in women with complex atypical hyperplasia of the endometrium, endometrial intraepithelial neoplasia, or grade 1 endometrial cancer as part of the Cancer Prevention Agent Development Program's early-phase clinical research initiative.
Place of performance is Madison, Wisconsin. The order carried no set-aside designation and was priced on a cost-no-fee basis. Ultimate completion was June 30, 2023. Service Contract Inventory reporting shows modest labor activity: FY2023 invoiced $59 thousand across 0.6 FTEs and 1,155 contractor hours, with a derived government-paid hourly rate of $50.99/hr. The university subcontracted 100 percent of contractor hours in FY2023. Invoiced labor and rates rose across reported fiscal years, from $27 thousand in FY2020 to $59 thousand in FY2023, with derived hourly rates increasing from $37.03/hr in FY2021 to $50.99/hr in FY2023.
Quick answers
Who was awarded contract HHSN26100011?
HHSN26100011 was awarded to University Of Wisconsin System by National Cancer Institute (National Institutes of Health) on September 15, 2017.
How much is contract HHSN26100011 worth?
The government has obligated $1,219,744 on HHSN26100011.
Is contract HHSN26100011 an order under another contract?
Yes. HHSN26100011 is a delivery order under HHSN261201200033I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.
Was contract HHSN26100011 competed?
The extent of competition for HHSN26100011 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award